Ori Biotech
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $141M
Investors
- 8
About Ori Biotech
Founded in 2015 and headquartered in London, UK, Ori Biotech Ltd specializes in the development of advanced manufacturing processes for cell and gene therapies.Ori Biotech Ltd specializes in advancing the manufacturing processes of cell and gene therapies through its core product, the IRO® platform. This cloud-native solution is designed to enhance biological performance while maintaining the benefits of automation, effectively addressing the challenges of high manufacturing costs, low throughput, and variability that plague the industry. The IRO® platform streamlines the development and manufacturing processes, enabling scientists to achieve high-quality cell production essential for successful patient outcomes. Ori Biotech's products cater to a diverse client base that includes Contract Development and Manufacturing Organizations (CDMOs), healthcare providers, and research institutions focused on translating therapeutic innovations into scalable production.10 in the most recent year, 2023. The company operates with a focus on partnerships with CDMOs and commercial manufacturers, engaging in long-term agreements where clients utilize the IRO® platform for their manufacturing needs. The company aims to enhance its product offerings and expand into new markets, particularly focusing on regions with growing demand for gene therapies.
Who invested in Ori Biotech
8 investors across 3 rounds
See all investors in Ori Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ori Biotech
Who invested in Ori Biotech?
Ori Biotech has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ori Biotech raised?
Ori Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ori Biotech last raise money?
Ori Biotech's most recent round on record is a Series B, in Dec 2021.
What does Ori Biotech do?
Founded in 2015 and headquartered in London, UK, Ori Biotech Ltd specializes in the development of advanced manufacturing processes for cell and gene therapies.
Where is Ori Biotech headquartered?
Ori Biotech is headquartered in London, UK.
Which VCs invest in companies like Ori Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ori Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ori Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.